• PGA, MLB changes CBD policies; other leagues evaluating policy changes regarding marijuana, CBD use
• Global market for CBD oil projected to grow from $967.2 million in 2020 to $5.3 billion by 2025
• WTER offers an exclusive line of A88CBD(TM) products, ranging from tinctures, capsules and gummies to lotion, creams salves

Since CBD was removed from professional golf’s banned substance list in 2018, PGA and Champions Tour players are turning more frequently to the plant to treat aches and pains, and golfers aren’t the only athletes to choose the compound. Earlier this year, Major League Baseball removed marijuana from its banned-substance list during the offseason (https://ibn.fm/G0lyQ). The benefits of CBD use by athletes are still being studied, but the Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) offers an exclusive line of A88CBD(TM) products(https://ibn.fm/KeIXt) that provide those benefits to sports enthusiasts — and anyone else looking for high-quality CBD-infused options.

“Billy Horschel went six months without a top-eight finish last year before he found a remedy for his ailing golf game from a surprising source: the hemp plant,” reported a recent “New York Times” article (https://ibn.fm/SBglV). “Horschel, a five-time PGA Tour winner, began using cannabidiol, or CBD, products shortly after he missed the cut at the British Open in July. He had four top-eight finishes in the next four months and was playing some of the most consistent golf of his career before the season was suspended in March because of the coronavirus pandemic. . . . He is the latest in a growing group of tour members, including Bubba Watson, a two-time Masters champion, and Scott McCarron, the reigning Schwab Cup winner on the Champions Tour, who are paid endorsers for CBD products.”

In addition to golf and the MLB, an ESPN article reports that CBD use is allowed in the National Women’s Soccer League. The substance is currently prohibited in the NFL, NBA, MLB and NHL. However, “the NBA has also expressed interest in revising its bylaws against CBD use. In 2018, CBD was removed from the World Anti-Doping Agency’s banned substances list” (https://ibn.fm/nxnoR).

The same article noted that CBD, short for cannabidiol, “has often been touted as a cure-all of sorts. Manufacturers and users claim, mostly anecdotally, that it has given them relief from muscle soreness and swelling and helped curb stress and anxiety. . . . Hemp-based CBD is legal — in various forms from ingestible oils to topicals — in all but three states in the U.S. and is legal at the federal level. States have their own rules restricting or allowing CBD products to be sold, and in many states, CBD can be sold over the counter in drug stores. It remains unregulated by the Federal Drug Administration, however.”

The ESPN article reported that the global market for CBD oil should grow from $967.2 million in 2020 to $5.3 billion by 2025 — all without CBD brands being allowed to directly advertise their products on social media.

WTER chairman Aaron Keay, a former Canadian national soccer team member, is an advocate for CBD use in sports, as well as other aspects of everyday use. “If you look at the kind of the athlete adoption of it, it kind of coincides with how the world is taking it on and looking at it. But you have a few movers and shakers that are willing to take the risk and say: ‘Look, CBD is going to become mainstream way ahead of cannabis and THC,'” Keay told ESPN. The Alkaline Water Company Inc. is a proud supporter of sports; the company’s brand ambassador Chez Reavie, who wears WTER’s flagship Alkaline88 logo on his shirt and sports an Alkaline88 golf bag at all PGA events, won the 2019 Travelers Championship Tournament.

The Alkaline Water Company offers an exclusive line of A88CBD(TM) products, ranging from tinctures, capsules and gummies to lotion, creams salves. The A88CBD products are formulated using high-quality, U.S.-grown hemp and made with 100% natural ingredients, cruelty-free, and gluten-free ingredients.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88, is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. In 2019, Alkaline88 launched A88 Infused(TM) to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020 the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water.

To learn more about this company, please visit www.TheAlkalineWaterco.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• HempFusion’s current product offerings, already available in stores, include tinctures, capsules, OTC topicals, edibles, probiotics and a doctor/practitioner line
• The company abides by all FDA regulations for its full line of products. It is one of few companies marketing FDA Drug Listed Topicals
• HempFusion is currently one of 12 CBD companies conducting a study addressing FDA concerns regarding CBD products and human safety
• The significant time and capital invested in HempFusion’s compliance provide the company with a competitive advantage in the expanding CBD market
• The CBD sector is projected to reach $16.8 billion by 2025
• The company has the second-largest cash presence in the market at $18.3 million as of June 30, 2020, and it is preparing to launch an IPO and list on the Toronto Stock Exchange under ticker symbol ‘CBD.U’

HempFusion Wellness is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition.

Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.

HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’. Learn More About HempFusion Upcoming IPO.

HempFusion is headquartered in Denver, Colorado.

HempFusion’s Proprietary Wellness Portfolio

The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.

HempFusion’s Diversified Revenue Pipeline

HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:

• Natural Health Retailers
• eCommerce
• Big Box / Food and Drug Mass
• Doctor Practitioner
• Convenience

HempFusion’s Line of Products

HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition-specific, targeting needs such as sleep, energy and stress.

All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s offerings span multiple product categories, including:

• Tinctures and capsules – These offerings make up the most popular product category in the $4 billion U.S. CBD market.
• OTC topicals – HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
• Condition-specific OTC products – HempFusion has OTC products that are condition-specifically targeted, including:

• • OTC Pain Products – The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
  • OTC Eczema Products – The global dermatitis market is projected to reach $13.6 billion by 2026.
  • OTC Acne and Aging/Beauty Products – The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
  • OTC First Aid and Wound Healing Products – In 2019, the 10 top-selling first aid ointments in the United States generated over $650 million in sales.

Probulin Probiotics and Digestive Enzymes

Probulin Probiotics is a 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States, according to Spins syndicated data.

The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products. The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022.

Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products.

This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future.

HF Labs and Biome Research – Doctor and Practitioner Product Lines

The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.

Research on CBD and Human Safety

HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.

As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.

Management Team

Jason Mitchell, N.D., is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.

Ian DeQueiroz is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He is a serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States. DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.

Jon Visser is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.

Bruce Valentine Jr. is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.

Ola Lessard is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.

Nancy Angelini is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.

Daniel Brody is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms.

For more information, visit the company’s website at www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion

• Security robot developer Knightscope has created autonomous sentry models that patrol properties and collect data to maintain a heightened level of public safety
• The company currently markets a K1 stationary machine, K3 indoor machine and K5 outdoor machine that have helped criminal incident investigators and provide a measure of deterrence simply through their presence
• The privately held company is backed by over 16,000 investors and four major corporations and has raised more than $70 million since its inception in 2013
• Robots’ features include 360-degree eye-level HD streaming video, people detection and facial recognition features, automatic license plate recognition, thermal anomaly detection, and automatic signal detection
• A security project for the Veterans Administration this year marked Knightscope’s first agreement with the federal government

Autonomous Security Robot developer Knightscope is using the technological prowess of artificial intelligence in its roving mechanical sentinels as a futuristic means of responding to the nation’s security needs and shortcomings inherent in personnel issues.

Knightscope’s automated sentinels have the capacity to patrol properties on a 24/7 basis 365 days a year, potentially averting crime merely through their presence and retrieving data that can then be used strategically by monitoring personnel to solve crimes that have taken place.

The various robot models feature 360-degree eye-level HD streaming video, people detection and facial recognition features, automatic license plate recognition, thermal anomaly detection, and automatic signal detection.

Knightscope robots have demonstrated their capabilities in a number of emergency response situations. The company notes they have assisted in arrests stemming from armed robbery and vehicle theft, burglary and property damage incidents. One security robot’s thermal camera identified a heat anomaly within a business that alerted responders to a developing fire hazard. Other data assists in law enforcement investigations have included cases involving fraud, hit and run damage, bicycle thefts and sexual predators (https://ibn.fm/mSyO1).

In July, the company announced an agreement to use one of its models at the Audie L. Murphy Memorial Veteran’s Hospital in San Antonio, Texas — Knightscope’s first federal government project and one it hopes the U.S. Department of Veterans Affairs Police Department will expand to more government client opportunities (https://ibn.fm/kLJAc). The company celebrated the robot’s deployment in a social media post this month (https://ibn.fm/5pyjU).

Knightscope is a private company backed by more than 16,000 investors and four major corporations, and has raised more than $70 million since it began in 2013.

“Our long-term mission is to make the United States of America the safest country in the world – and with your continued support, we will reimagine public safety, together, at a time when our Nation needs it most,” the company’s chairman and CEO William Santana Li states (https://ibn.fm/EGBLB).

For more information, visit the company’s website at www.Knightscope.com

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• SRAX sells remaining MD ownership stake for $8 million
• MD sale allows SRAX to focus on rapid growth of Sequire platform
• Sequire unlocks big data investor insights for public companies
• Sequire revenue grew 29% year-over-year for Q2 2020, user base doubled to one million users during Q3 2020

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has recently sold its remaining stake in its MD healthcare vertical for $8 million.

SRAX’s final divestment in MD represents the latest in a series of strategic moves that are further solidifying SRAX’s position in the investment industry. Along with spinning off its proprietary data-based BIGtoken platform into its own private company, SRAX has also acquired LD Micro, a leading data and event company serving the small and micro-cap space that provides exclusive information on micro-cap North American stocks.

“Our Sequire platform is rapidly growing and we are focused on the continued expansion of this business,” said SRAX founder and CEO Christopher Miglino (https://ibn.fm/0vwNh). “We believe that selling the MD ownership stake at this time reinforces our goal of being 100% focused on providing our platform and services to public companies. This capital will be effective in helping us accelerate growth. This asset currently sits on our balance sheet with a zero basis, so this capital will go directly to improving our balance sheet. This transaction combined with moving Bigtoken to its own public company brings clarity to our mission going forward.”

Sequire’s suite of tools allows public companies to unlock the power of investor data through warrant tracking, survey creation, events and roadshows, and customer relationship/resource management (“CRM”). Since its creation in 2019, the platform has grown rapidly, doubling its user base to over one million investors and traders across 91 public companies in just two months (https://ibn.fm/wv6L7) in addition to posting Q2 earnings that showed a 29% increase in year-over-year revenue. The acquisition of LD Micro is expected to further accelerate the adoption of Sequire, paving a new road forward for both companies.

“The platform is an absolute game-changer for public companies and their shareholders,” said LD Micro founder Chris Lahiji in recent statements (https://ibn.fm/ACfcV). “Both companies believe that one day executives will rely on Sequire the same way investors rely on Bloomberg.”

SRAX is on the Russell Microcap(R) Index in addition to being invited to the board of the Interactive Advertising Bureau (“IAB”) Data Policy Board. Through the creation of specialized tools that reveal core consumers and their characteristics, SRAX continues to leverage the growing demand for quantifiable and detailed consumer data across a wide range of industries.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• SGMD releases key numbers for BudCars Q3 2020 financial report
• CEO reports that company “continues to perform, setting records in basically every key metric we track”
• BudCars has seen consistent growth since Sugarmade acquired 40% stake in the Sacramento-based cannabis delivery service

Steadily growing gross margins, more than 60% growth and $2 million in gross receipts are a few of the highlights in an announcement (https://ibn.fm/8gnHK) made by Sugarmade (OTCQB: SGMD) featuring the Q3 2020 numbers for BudCars Cannabis Delivery Service. SGMD owns a 40% stake in BudCars, along with an option to acquire an additional 30%.

“BudCars continues to perform, setting records in basically every key metric we track,” said Sugarmade CEO Jimmy Chan. “It was a tremendous quarter, with a big jump in customers and regional market share and robust margins on every sale. That paints a very motivating picture as we gear up to significantly expand our service territory, with upcoming expansion into the North Bay and Wine Country areas, as well as our upcoming grand opening of BudCars LA.”

The preannouncement of BudCars’ performance for the three months ended Sept. 30, 2020, included the following key numbers:

• Total Q3 2020 BudCars gross receipts over $1.9 million, which represents a 66% increase quarter over quarter
• Total Q3 BudCars gross profits of $903,667, representing 64% gross profit growth quarter over quarter on a steady 47% gross profit margins
• Average daily gross sales increased $21,246, a 68% increase quarter to quarter
• Total customer tickets increased 62% quarter to quarter on 3% growth in average ticket size

BudCars has seen consistent growth since Sugarmade acquired a 40% stake in the Sacramento-based cannabis delivery service earlier this year (https://ibn.fm/jjr74). In fact, the company has performed ahead of expectations almost every month since March 2020, seeing consistent growth in almost every area, including increasing new customers, strong repeat business, increasing orders per customer per period, and increasing ticket sizes.

BudCars isn’t the only bright spot on the Sugarmade horizon. The company also recently secured rights to a property zoned for cannabis cultivation (https://ibn.fm/ps9IP). The company is already in the process of obtaining cannabis cultivation licensing, preparing archaeological and biological surveys, and assembling documentation related to the architectural and engineering plans for construction of greenhouses and a processing building.

“We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” said Chan. “We also have relationships in place, especially through our BudCars investment, to hit the ground running on the branded products side, driving strong margins up and down the chain.”

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. Sugarmade is an investor in BudCars and a joint operator of BudCars’ first operating location in Sacramento, California.

During early 2020, Sugarmade gained a 40% stake in BudCars and in the Sacramento delivery operations via the acquisition of a 40% stake in Indigo Dye Group (Indigo). Under the terms of Sugarmade’s agreement with Indigo, Sugarmade also acquired an option to purchase an additional 30% interest in Indigo, upon the closing of which would provide Sugarmade with a 70% controlling interest. As of the date hereof, this option has not yet been exercised; Sugarmade’s stake in Indigo remains at 40%, and there is no assurance that Sugarmade will exercise the option to acquire an additional 30% interest in Indigo.

However, since late May 2020, Sugarmade has been actively involved in development of Indigo’s operations with power to direct the activities and significantly impact Indigo’s economic performance. Sugarmade also has obligations to absorb losses and right to receive benefits from Indigo. As such, in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification 810-10-25-38A through 25-38J, Indigo is considered a variable interest entity (“VIE”) of Sugarmade.

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS:: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Plant-based superfood developer Rritual Mushrooms Inc. has produced its initial product lineup of three functional mushroom elixirs and powders designed to boost personal wellness
• The company was recognized by retail marketing agency ECRM for its attractive product presentation and growing success, as judged by national outlets including CVS, Vitamin Shoppe, Amazon and Rite Aid
• The functional mushroom market is a nascent subsection of the wellness industry ripe with potential for companies that get in on the ground floor as expectations for the industry grow
• Rritual’s Reishi Relax, Chaga Immune and Lion’s Mane Focus formulations are available in 14-stick packs and in 250-gram tubs, as well as in a 14-day variety pack that includes all three elixirs

Lifestyle therapeutics innovator Rritual Mushrooms gained recognition for its development of attractive marketing and its growing market presence at the 2020 annual ECRM Buyer’s Choice Awards.

The awards spotlight Efficient Collaborative Retail Marketing, and Rritual Mushrooms achieved second place in the Whole Body & Mind Wellness category, which was voted on by wellness product buyers from national retail outlets in a virtual event last month (https://ibn.fm/xEIAx).

“Rritual’s performance at the ECRM Buyer’s Choice Awards was not only a vote of confidence for the long-term potential of our product line but also a clear indication that there is strong demand for high-quality and accessible mushroom products among mainstream consumers and retailers alike,” Rritual’s CEO David Kerbel stated.

Rritual Mushroom is a premium brand in the functional mushroom market, an industry that is still in its infancy and ripe with potential for early movers. Certain mushrooms have long been touted for their beneficial properties — as an example, the Reishi mushroom enjoys a reputation as “the mushroom of immortality” after thousands of years of use in traditional Chinese medicine for boosting the immune system, fighting off cancer, fatigue and depression, supporting heart health, and helping to control blood sugar levels (https://ibn.fm/T5mVn).

Rritual has introduced an initial product line of elixirs, shots and mixes for three mushroom varieties paired with select adaptogens — herbal substances used to increase the body’s ability to resist biological stress (https://ibn.fm/JzamN). In addition to Reishi, which is paired with the adaptogen Ashwagandha root, Rritual’s products pair the Chaga mushroom with Eleuthero root and the Lion’s Mane mushroom with Rhodiola root.

“I believe Rritual has a great business model and product portfolio, in addition to a talented and passionate management team that uniquely positions it for success in the emerging plant-based industry,” Dr. Mike Hart, the company’s new president stated when he was hired in June (https://ibn.fm/rQY5o). “Their mission to help people adapt to modern life and prove that mushrooms are one of the world’s greatest superfoods is a perfect fit with my own wellness practices as a physician, and personally as an individual who is passionate about mental and physical health.”

Each Reishi Relax, Chaga Immune and Lion’s Mane Focus elixir also contains a blend of six functional mushrooms including turkey tail, shiitake and maitake, as well as a prebiotic blend featuring inulin and lucuma fruit powder, which together are designed to support immune and digestive health.

ECRM VP of Health and Beauty Care Craig Chmielowicz noted the timeliness of Rritual’s product offering, stating, “A big part of wellness these days — especially during the pandemic — includes finding ways to relax the body and mind” (https://ibn.fm/tO6y8).

For more information, visit the company’s website at https://Investors.WeAreRritual.com.

“Mental Fitness is a Daily Ritual”

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual

• Majority of game developers surveyed believe that eSports industry will continue to grow in coming years
• eSports attracts the largest audience on the planet at more than 600 million people
• Colleges, universities and high schools now offering eSports as academic classes with opportunities for scholarships

Mobius Interactive is an online gaming operator featuring various unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading and award-winning eSports and iGaming platform, the company seeks to attract a network of high net-worth gamers from around the world.

Mobius.Bet is the company’s dedicated eSports hub catering to the growing eSports segment. By the end of 2021, the sector will reach 2.7 billion gamers playing worldwide, according to Mobius CEO Lynn Pearce, in a recent “Infinity Gaming” article (https://ibn.fm/7b0Y8).

Pearce isn’t the only one forecasting growth in the space. Perforce, an American developer of software used for developing and running applications, recently surveyed game development professionals and found that the majority believe that the eSports industry will only continue to grow in the coming year (https://ibn.fm/AaCQP). This is in part due to the impact of COVID-19. As individuals look for more ways to stay connected and entertained, eSports will only continue to grow.

Earlier this year, “The Manual” reported that eSports attracts the largest audience on the planet at over 600 million people (https://ibn.fm/rqP1c). At the beginning of the pandemic, it was one of the few remaining social activities and live-entertainment options available. According to the “LA Times,” eSports was built for quarantine culture and had eight million people logging on daily (https://ibn.fm/zHqFI).

However, the popularity of eSports was actually growing before the world was forced to stay home and find new avenues of entertainment. Well before COVID-19, more than 170 colleges and universities were participating in eSports. High schools have created eSports classes, not categorized as sports but as an academic class. College scholarships, tournament money and high salary jobs are now possibilities in the space. Gaming is no longer solitary. It has become a social activity that pushes players to their best, develops skills, and requires teamwork and strategy (https://ibn.fm/gn8aV).

One of the main challenges pointed out by Pearce and those surveyed by Perforce is funding. Monetizing eSports is not an easy endeavor. Part of the challenge is the speed of sports and the thrill of betting in the fast-paced arena. eSports is slower, with games, competitions and tournaments lasting longer. Fans, especially those placing bets, want instant action.

Or they did. With COVID-19 slowing down lives and shifting attention from what was once the norm, there is a new interest and patience in the eSports arena. And that interest is accompanied by funding.

As an online gaming operator featuring a variety of unique offerings catering to diverse demographic groups, Mobius Interactive is well positioned to leverage the growing interest as smart money is increasingly betting on esports. The company is partnering with award-winning eSports and iGaming platform Ultra Play and more than 600 VIP and master-gaming affiliates seeking to attract high-net-worth gamers worldwide. Led by management with experience in eSports and handling the launches of more 30 successful products within the last three years, Mobius Interactive is set out to become a notable player in this growing sector.

To learn more about this company, visit www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• New research reports that almost half of music fans want virtual concerts to continue
• FDBL’s Fan Pass platform just offered first-ever livestream Halloween concert
• Company’s vision already beginning to redefine artist-fan relationship

Livestreaming concerts are a creative byproduct of the global pandemic, a modern-day solution to the heartbreaking cancellation of live performances and concerts. A new Music 360 report by MRC Data, however, suggests that almost half of music fans want virtual concerts to continue, even after COVID-19 restrictions are eased (https://ibn.fm/CUjyX). That’s music to the ears of Friendable (OTC: FDBL), which just wrapped its first-ever livestreaming Halloween concert, which featured artists S-mack (x2), Mamd, R.T.A and Ball Hog Beats.

“The livestream business has become a necessity since the start of the pandemic,” reported a recent “EDMTunes” article, titled “Half of Music Fans Want Virtual Concerts to Stay” (https://ibn.fm/GgXyI). “Its current prevalent importance has left a positive impact on the industry. This is why virtual concerts are likely to stick around once venues and concert halls resume operations.”

Friendable, a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, is banking on that being the case. Earlier this year, the company launched its flagship product, the Fan Pass app. Fan Pass is a livestreaming platform that supports artists at all levels, providing exclusive artist-content channels, livestreaming events, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist. The recent Fan Pass Halloween event featured artists who recently approved their artist channels on the Fan Pass platform and now have the ability to schedule, promote and hold virtual events (https://ibn.fm/HbNfF).

“We, along with our friends, family and staff, enjoyed viewing each one of these performances,” said Friendable CEO Robert A. Rositano Jr. “Even more enjoyable was the excitement expressed in discussions centering on all Fan Pass has to offer, and we envision a bright future for the platform and our brand.

“In total, the events generated over 15,933 impressions by approximately 124 users, as well as attracting more than 545 fan interactions with artist content, which continues to show traction and display how our model works,” Rositano continued. “We believe our vision is already beginning to redefine the artist-fan relationship as we push forward to support each artist at every level and work to simultaneously uncover new revenue opportunities for them. Thank you to all our performers, their fans and our shareholders for your support.”

The Halloween event, the first of several holiday-themed livestream events planned for the upcoming season, lasted more than three hours and is available for fans to view via the Fan Pass app or the Fan Pass website using the “Live on Demand” playback feature.

Friendable’s Fan Pass app, artists can offer exclusive content channels to their fans, who simply use their smartphones to gain access to their favorite artists as well as an all-access pass, giving them access to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists — all available to fan subscribers for free on a trial basis. Following the trial, subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, providing VIP access at a fraction of the cost of traditional face-to-face meetups.

For more information about Friendable or the Fan Pass platform, services and offering, visit the company’s website at www.Friendable.com or www.FanPassLive.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition
• Results garnered from company’s HSC optimization are unparalleled in field
• Soluble Biotech lands first major contract, signifying major company milestone

Offering a proprietary automated High Throughput Self-Interaction Chromatography(TM) (“HSC”) Technology Platform, Predictive Oncology (NASDAQ: POAI) provides biomedical and pharmaceutical companies with superior options never before available. A knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, POAI, through its subsidiary Soluble Biotech, delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations.

HSC Technology is a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations (https://ibn.fm/vbZ53). The data generated from these screens is analyzed by a predictive algorithm used to identify the optimal combination of additives and excipients, resulting in increased solubility and physical stability of proteins. And while the technology produces unparalleled optimization results, it provides other benefits as well.

Using current methods, optimization can take more than a year, cost hundreds of thousands of dollars and require teams of five or more individuals to complete. Optimization with HSC, on the other hand, takes only three months, costs tens of thousands of dollars, and needs just one individual to conduct. The comparison is stark — and irresistible. Soluble Biotech has already finalized its first substantial contract since being acquired by POAI earlier this year and is currently negotiating additional contracts (https://ibn.fm/rZyMr).

“Our first contract is a major milestone and validates our recent move into a new, larger facility,” said Soluble Biotech founder Dr. Larry DeLucas, who is also a former NASA astronaut. “We quadrupled our laboratory and office space, some of which will eventually include a GMP facility. Additionally, we acquired state-of-the-art equipment to support our fermentation, therapeutic protein formulation development and protein stability studies.”

A provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes, Soluble Biotech is fast becoming recognized for its expertise in enhancing the drug-development process by rapidly optimizing protein solubility and stability. The company brings proprietary transformational technology to formulation development for protein-based pharmaceuticals and vaccines. In addition, its solubilization and stability technology is used at academic, pharmaceutical and government laboratories involved in conducting fundamental protein research.

Soluble Biotech’s exclusive HSC technology was developed by Dr. William Wilson, a former chairman of the chemistry department at Mississippi State University, and DeLucas; the two have spent almost 20 years developing the game-changing technology and tool. HSC has been validated over the past decade through numerous industry and academic collaborations with several clients seeing tenfold and even hundredfold increases in their protein’s solubility while also maintaining physical stability. For the pharmaceutical sector, this means faster development times and quicker progression of molecules into the clinic. In academics, these results lead to further progression of biochemical and biology studies that are vital to advance fundamental research in areas of unmet medical need.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM
• SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment
• Mulch Manufacturing recently secured many new contracts that include The Kroger Co., Circle K, Menards Inc. and Old Castle Lawn & Garden
• SGTM’s Q2 results nearly doubled from previous quarter; include $12.3 million revenue, $3.4 million gross profit

Proving the theory that the whole is greater than the sum of its parts, National Storm Recovery Inc. recently acquired Mulch Manufacturing Inc. to create the Sustainable Green Team (OTC: SGTM) – a leading provider of environmentally-beneficial solutions for tree and storm waste disposal. Besides increased sales, greater profits and international expansion, the synergistic activities of both companies further solidify their shared roles as stewards of the environment through the creation of organic products that benefit nature while diverting natural waste from landfills.

“With Mulch Manufacturing’s national and international distribution, its sales contracts with many big box retailers, and the increase in production and packaging capacity it provides, this strategic acquisition has positioned us as The Sustainable Green Team,” said SGTM CEO Tony Raynor at the time of the acquisition (https://ibn.fm/ct1we).

SGTM primarily provides solutions for the treatment and handling of tree debris created by storms that typically gets sent to disposal sites. Along with creating additional pressure on landfills, this natural waste further increases municipal expenses while contributing to the overall environmental burden experienced across the nation. With over 40 years of combined next-level experience, SGTM provides services that convert this problem into profits by collecting, treating and caring for these trees and transforming them into products that include garden mulch and playground surfacing material.

Besides making good economic sense, the move continues to pay dividends in the form of increased profits – despite the economic recession connected to COVID-19. SGTM just keeps on growing, and part of that growth is attributed to contracts between Mulch Manufacturing and large industry players like The Kroger Co., Circle K, Menards Inc., Old Castle Lawn & Garden, and many more.

“This business combination has created an industry power house; and with our combined strengths, puts us in an ideal position to increase our sales and resulting margins, as our combined operations benefit from the resulting vertical integration and economies of scale,” noted Mulch Manufacturing CEO Ralph Spencer.

Management forecasts at the time of the acquisition have materialized with better results than expected. SGTM’s profits nearly doubled in a quarter, leading to impressive Q2 results that include $12.3 million in revenue and $3.4 million in gross profit (https://ibn.fm/ySmKU). Along with the increased contracts from Mulch Manufacturing, much of this growth can also be attributed to relief efforts in the wake of Hurricane Laura along with new contracts between SGTM’s strategic partners and state municipalities.

STGM’s strong commitment to environmental sustainability served as a primary motivation behind the name and ticker change from National Storm Recovery Inc. (OTC: NSRI) to Sustainable Green Team, Ltd. (OTC: SGTM). Along with driving forward its environmental mission, the company is also committed to maximizing shareholder value, particularly for investors looking to leverage profitable – and ethical – opportunities during times of economic uncertainty.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/OSR73.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM